A total of 45.3% of NSCLC samples showed strong CTNNB1 expression, while the percentages of moderate and weak CIRP expression were 36.1 and 18.6%, respectively (Supplementary Fig. 6B). The gene discussed is CTNNB1; the disease is non-small cell lung carcinoma.